Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Innovations in Microfluidics, Biofabrication, Synthetic Biology
Conferences  \  BioEngineering 2018  \  Innovations in Microfluidics, Biofabrication, Synthetic Biology  \  Agenda  \  Fabien Guillemot
RegisterLogin

Fabien Guillemot's Biography


Fabien Guillemot, CEO, Poietis

Dr. Fabien Guillemot is the founder of Poietis, a bioprinting company which harnesses the Laser-Assisted Bioprinting technology to fabricate complex and customized tissues for regenerative medicine and pharmaceutical applications. He obtained his PhD in Materials Science in 2000 from the National Institute for Applied Sciences (Rennes, France). He was appointed in 2005 Senior Researcher at the National Institute for Health and Medical Research (INSERM, France). He initiated and led till 2014 the project Tissue Engineering Assisted by Laser (TEAL) which aimed at developing laser-assisted technologies for fabricating artificial tissues into which cells are organized into defined 3D micro-environments. Dr. Guillemot is the author of more than 50 articles in peer-reviewed journals and about 40 invited conferences.

Fabien Guillemot Image

Towards Bioprinting Industrialization

Tuesday, 27 March 2018 at 14:30

Add to Calendar ▼2018-03-27 14:30:002018-03-27 15:30:00Europe/LondonTowards Bioprinting IndustrializationSELECTBIOenquiries@selectbiosciences.com

Bioprinting has been defined as “the use of computer-aided transfer processes for patterning and assembling living and non-living materials with a prescribed 2D or 3D organization in order to produce bio-engineered structures serving in regenerative medicine, pharmacokinetic and basic cell biology studies”.

From a technological point of view, different bioprinting technologies have been developed so far. Recently, Laser-Assisted Bioprinting (LAB) technology has emerged as an alternative method to inkjet and bioextrusion methods, thereby overcoming some of their limitations (namely clogging of print heads or capillaries) to pattern living cells and biomaterials with a micron-scale resolution and high cell viability.

During this presentation, we will present current development on the industrialization of bioprinting process, namely in the context of manufacturing 3D skin models.

Add to Calendar ▼2018-03-26 00:00:002018-03-27 00:00:00Europe/LondonInnovations in Microfluidics, Biofabrication, Synthetic BiologySELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors
Related Conferences
Organoids, Spheroids & Organs-on-Chips 2024
Location: Laguna Hills, California
Date: 18/11/2024 - 20/11/2024


Organoids and Spheroids Europe 2024
Location: Rotterdam, The Netherlands
Date: 24/06/2024 - 25/06/2024


Lab-on-a-Chip, Microfluidics, & Organ-on-a-Chip Asia 2024
Location: Tokyo, Japan
Date: 07/11/2024 - 08/11/2024